942 related articles for article (PubMed ID: 25981963)
21. MDM4 enhances p53 stability by promoting an active conformation of the protein upon DNA damage.
Di Conza G; Mancini F; Buttarelli M; Pontecorvi A; Trimarchi F; Moretti F
Cell Cycle; 2012 Feb; 11(4):749-60. PubMed ID: 22374672
[TBL] [Abstract][Full Text] [Related]
22. AAV-mediated inhibition of ULK1 promotes axonal regeneration in the central nervous system in vitro and in vivo.
Ribas VT; Vahsen BF; Tatenhorst L; Estrada V; Dambeck V; Almeida RA; Bähr M; Michel U; Koch JC; Müller HW; Lingor P
Cell Death Dis; 2021 Feb; 12(2):213. PubMed ID: 33637688
[TBL] [Abstract][Full Text] [Related]
23. Restoring Cellular Energetics Promotes Axonal Regeneration and Functional Recovery after Spinal Cord Injury.
Han Q; Xie Y; Ordaz JD; Huh AJ; Huang N; Wu W; Liu N; Chamberlain KA; Sheng ZH; Xu XM
Cell Metab; 2020 Mar; 31(3):623-641.e8. PubMed ID: 32130884
[TBL] [Abstract][Full Text] [Related]
24. Adenoviral E1A targets Mdm4 to stabilize tumor suppressor p53.
Li Z; Day CP; Yang JY; Tsai WB; Lozano G; Shih HM; Hung MC
Cancer Res; 2004 Dec; 64(24):9080-5. PubMed ID: 15604276
[TBL] [Abstract][Full Text] [Related]
25. Dual inhibition of MDM2 and MDM4 in virus-positive Merkel cell carcinoma enhances the p53 response.
Park DE; Cheng J; Berrios C; Montero J; Cortés-Cros M; Ferretti S; Arora R; Tillgren ML; Gokhale PC; DeCaprio JA
Proc Natl Acad Sci U S A; 2019 Jan; 116(3):1027-1032. PubMed ID: 30598450
[TBL] [Abstract][Full Text] [Related]
26. MDM2 and MDM4: p53 regulators as targets in anticancer therapy.
Toledo F; Wahl GM
Int J Biochem Cell Biol; 2007; 39(7-8):1476-82. PubMed ID: 17499002
[TBL] [Abstract][Full Text] [Related]
27. Low intensity repetitive transcranial magnetic stimulation does not induce cell survival or regeneration in a mouse optic nerve crush model.
Tang AD; Makowiecki K; Bartlett C; Rodger J
PLoS One; 2015; 10(5):e0126949. PubMed ID: 25993112
[TBL] [Abstract][Full Text] [Related]
28. Targeting the MDM2/MDM4 interaction interface as a promising approach for p53 reactivation therapy.
Pellegrino M; Mancini F; Lucà R; Coletti A; Giacchè N; Manni I; Arisi I; Florenzano F; Teveroni E; Buttarelli M; Fici L; Brandi R; Bruno T; Fanciulli M; D'Onofrio M; Piaggio G; Pellicciari R; Pontecorvi A; Marine JC; Macchiarulo A; Moretti F
Cancer Res; 2015 Nov; 75(21):4560-72. PubMed ID: 26359458
[TBL] [Abstract][Full Text] [Related]
29. Regulation of MDM4 (MDMX) function by p76(MDM2): a new facet in the control of p53 activity.
Giglio S; Mancini F; Pellegrino M; Di Conza G; Puxeddu E; Sacchi A; Pontecorvi A; Moretti F
Oncogene; 2010 Nov; 29(44):5935-45. PubMed ID: 20697359
[TBL] [Abstract][Full Text] [Related]
30. Sprouting of axonal collaterals after spinal cord injury is prevented by delayed axonal degeneration.
Collyer E; Catenaccio A; Lemaitre D; Diaz P; Valenzuela V; Bronfman F; Court FA
Exp Neurol; 2014 Nov; 261():451-61. PubMed ID: 25079366
[TBL] [Abstract][Full Text] [Related]
31. Downregulation of Mdm2 and Mdm4 enhances viral gene expression during adenovirus infection.
Yang H; Zheng Z; Zhao LY; Li Q; Liao D
Cell Cycle; 2012 Feb; 11(3):582-93. PubMed ID: 22262167
[TBL] [Abstract][Full Text] [Related]
32. Tissue-specific differences of p53 inhibition by Mdm2 and Mdm4.
Grier JD; Xiong S; Elizondo-Fraire AC; Parant JM; Lozano G
Mol Cell Biol; 2006 Jan; 26(1):192-8. PubMed ID: 16354690
[TBL] [Abstract][Full Text] [Related]
33. Tumor-specific signaling to p53 is mimicked by Mdm2 inactivation in zebrafish: insights from mdm2 and mdm4 mutant zebrafish.
Chua JS; Liew HP; Guo L; Lane DP
Oncogene; 2015 Nov; 34(48):5933-41. PubMed ID: 25746004
[TBL] [Abstract][Full Text] [Related]
34. MDM2 but not MDM4 promotes retinoblastoma cell proliferation through p53-independent regulation of MYCN translation.
Qi DL; Cobrinik D
Oncogene; 2017 Mar; 36(13):1760-1769. PubMed ID: 27748758
[TBL] [Abstract][Full Text] [Related]
35. Mutation at p53 serine 389 does not rescue the embryonic lethality in mdm2 or mdm4 null mice.
Iwakuma T; Parant JM; Fasulo M; Zwart E; Jacks T; de Vries A; Lozano G
Oncogene; 2004 Oct; 23(46):7644-50. PubMed ID: 15361844
[TBL] [Abstract][Full Text] [Related]
36. Traumatology of the optic nerve and contribution of crystallins to axonal regeneration.
Thanos S; Böhm MR; Schallenberg M; Oellers P
Cell Tissue Res; 2012 Jul; 349(1):49-69. PubMed ID: 22638995
[TBL] [Abstract][Full Text] [Related]
37. A molecular mechanism of optic nerve regeneration in fish: the retinoid signaling pathway.
Kato S; Matsukawa T; Koriyama Y; Sugitani K; Ogai K
Prog Retin Eye Res; 2013 Nov; 37():13-30. PubMed ID: 23994437
[TBL] [Abstract][Full Text] [Related]
38. Axonal regeneration induced by blockade of glial inhibitors coupled with activation of intrinsic neuronal growth pathways.
Wang X; Hasan O; Arzeno A; Benowitz LI; Cafferty WB; Strittmatter SM
Exp Neurol; 2012 Sep; 237(1):55-69. PubMed ID: 22728374
[TBL] [Abstract][Full Text] [Related]
39. Resistance of interleukin-6 to the extracellular inhibitory environment promotes axonal regeneration and functional recovery following spinal cord injury.
Yang G; Tang WY
Int J Mol Med; 2017 Feb; 39(2):437-445. PubMed ID: 28075461
[TBL] [Abstract][Full Text] [Related]
40. Widespread overexpression of epitope-tagged Mdm4 does not accelerate tumor formation in vivo.
De Clercq S; Gembarska A; Denecker G; Maetens M; Naessens M; Haigh K; Haigh JJ; Marine JC
Mol Cell Biol; 2010 Nov; 30(22):5394-405. PubMed ID: 20855528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
